JP2024506385A5 - - Google Patents
Info
- Publication number
- JP2024506385A5 JP2024506385A5 JP2023548874A JP2023548874A JP2024506385A5 JP 2024506385 A5 JP2024506385 A5 JP 2024506385A5 JP 2023548874 A JP2023548874 A JP 2023548874A JP 2023548874 A JP2023548874 A JP 2023548874A JP 2024506385 A5 JP2024506385 A5 JP 2024506385A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163149944P | 2021-02-16 | 2021-02-16 | |
| US63/149,944 | 2021-02-16 | ||
| PCT/US2022/016270 WO2022177844A1 (en) | 2021-02-16 | 2022-02-14 | Treatment of breast cancer using combination therapies comprising gdc-9545 and gdc-0077 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024506385A JP2024506385A (ja) | 2024-02-13 |
| JPWO2022177844A5 JPWO2022177844A5 (https=) | 2025-02-18 |
| JP2024506385A5 true JP2024506385A5 (https=) | 2025-02-18 |
Family
ID=80953424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548874A Pending JP2024506385A (ja) | 2021-02-16 | 2022-02-14 | Ｇｄｃ－９５４５及びｇｄｃ－００７７を含む併用療法を使用する乳がんの治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230381155A1 (https=) |
| EP (1) | EP4294395B1 (https=) |
| JP (1) | JP2024506385A (https=) |
| CN (1) | CN117377472A (https=) |
| ES (1) | ES3030540T3 (https=) |
| PL (1) | PL4294395T3 (https=) |
| TW (1) | TWI808648B (https=) |
| WO (1) | WO2022177844A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025163068A (ja) * | 2022-11-02 | 2025-10-28 | ペトラ・ファーマ・コーポレイション | 疾患の治療のためのホスホイノシチド３－キナーゼ（ｐｉ３ｋ）のアロステリックポケット及びオルソステリックポケットの標的化 |
| KR20250107982A (ko) * | 2022-11-02 | 2025-07-14 | 페트라 파마 코포레이션 | 질환의 치료를 위한 포스포이노시티드 3-키나제 (pi3k)의 알로스테릭 및 오르토스테릭 포켓 표적화 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102785474B1 (ko) | 2014-12-18 | 2025-03-26 | 에프. 호프만-라 로슈 아게 | 테트라하이드로-피리도[3,4-b]인돌 에스트로겐 수용체 조절제 및 이의 용도 |
| EP4212536B1 (en) | 2015-07-02 | 2025-02-19 | F. Hoffmann-La Roche AG | Benzoxazepin oxazolidinone compounds and methods of use |
| US20170362228A1 (en) * | 2016-06-16 | 2017-12-21 | Genentech, Inc. | TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF |
| LT3810283T (lt) * | 2018-06-21 | 2023-08-25 | F. Hoffmann-La Roche Ag | 3-((1r,3r)-1-(2,6-difluor-4-((1-(3-fluorpropil)azetidin-3- il)amino) fenil)-3-metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)- 2,2- difluorpropan-1-olio tartrato druskos kietosios formos, jų paruošimo procesas ir jų naudojimo būdai vėžiui gydyti |
| KR20210035211A (ko) * | 2018-07-23 | 2021-03-31 | 에프. 호프만-라 로슈 아게 | Pi3k 저해제인 gdc-0077로 암을 치료하는 방법 |
| CA3109090A1 (en) | 2018-08-17 | 2020-02-20 | F. Hoffmann-La Roche Ag | Diagnostic and therapeutic methods for the treatment of breast cancer |
| CN115175679A (zh) * | 2020-03-06 | 2022-10-11 | 奥列马制药公司 | 治疗雌激素受体相关疾病的方法 |
-
2022
- 2022-02-14 JP JP2023548874A patent/JP2024506385A/ja active Pending
- 2022-02-14 TW TW111105232A patent/TWI808648B/zh active
- 2022-02-14 CN CN202280015198.3A patent/CN117377472A/zh active Pending
- 2022-02-14 EP EP22713478.0A patent/EP4294395B1/en active Active
- 2022-02-14 WO PCT/US2022/016270 patent/WO2022177844A1/en not_active Ceased
- 2022-02-14 ES ES22713478T patent/ES3030540T3/es active Active
- 2022-02-14 PL PL22713478.0T patent/PL4294395T3/pl unknown
-
2023
- 2023-08-15 US US18/449,800 patent/US20230381155A1/en active Pending